Generic substitution and prescription drug prices : economic effects of state drug product selection laws

LDR 01618nam a2200421 a 4500
001 002589428
003 MiAaHDL
005 20221205000000.0
006 m d
007 cr bn ---auaua
008 930119s1985 dcu b f000 0 eng c
010 ‡a86600884
035 ‡a(MiU)990025894280106381
035 ‡asdr-miu.990025894280106381
035 ‡asdr-uiuc817905
035 ‡asdr-ucr.b1620332x
035 ‡z(MiU)MIU01000000000000002589428-goog
035 ‡a(OCoLC)13028157
035 ‡z(MiU)Aleph002589428
040 ‡aDGPO/DLC ‡cDLC ‡dGPO ‡dFDS ‡dNYP ‡dEYM
043 ‡an-us---
050 0 0 ‡aRS55.2 ‡b.M37 1985
074 ‡a535
082 0 0 ‡a615/.1 ‡220
086 0 ‡aFT 1.2:G 28
100 1 ‡aMasson, Alison.
245 1 0 ‡aGeneric substitution and prescription drug prices : ‡beconomic effects of state drug product selection laws / ‡cby Alison Masson and Robert L. Steiner.
260 ‡a[Washington, D.C.?] : ‡bBureau of Economics, Federal Trade Commission, ‡c1985.
300 ‡aviii, 340 p. ; ‡c23 cm.
490 0 ‡aStaff report of the Bureau of Economics, Federal Trade Commission
500 ‡aItem 535.
500 ‡a"October 1985."
500 ‡aShipping list no.: 85-1186-P.
504 ‡aBibliography: p. 333-340.
538 ‡aMode of access: Internet.
650 2 ‡aTherapeutic Equivalency ‡xlegislation.
650 2 ‡aFees, Pharmaceutical ‡xlegislation.
650 2 ‡aLegislation, Drug.
650 0 ‡aDrugs ‡xPrescribing ‡zUnited States.
650 0 ‡aDrugs ‡zUnited States ‡xGeneric substitution.
700 1 ‡aSteiner, Robert L.
710 1 ‡aUnited States. ‡bFederal Trade Commission. ‡bBureau of Economics.
899 ‡a39015028479155
CID ‡a002589428
DAT 0 ‡a19930507000000.0 ‡b20221205000000.0
DAT 1 ‡a20221208060740.0 ‡b2023-06-24T17:49:39Z
CAT ‡aSDR-MIU ‡cmiu ‡dALMA ‡lprepare.pl-004-008
FMT ‡aBK
HOL ‡0sdr-miu.990025894280106381 ‡aMiU ‡bSDR ‡cMIU ‡f002589428 ‡pmdp.39015028479155 ‡sMIU ‡1990025894280106381
974 ‡bMIU ‡cMIU ‡d20230624 ‡sgoogle ‡umdp.39015028479155 ‡y1985 ‡rpd ‡qbib ‡tUS fed doc
974 ‡bUIU ‡cUIUC ‡d20231003 ‡sgoogle ‡uuiug.30112047333668 ‡y1985 ‡rpd ‡qbib ‡tUS fed doc
974 ‡bUC ‡cUCR ‡d20240623 ‡sgoogle ‡uuc1.31210012722946 ‡y1985 ‡rpd ‡qbib ‡tUS fed doc